Form 4: Amarin Director Diane E. Sullivan Receives Stock Options and Restricted Stock Units

Director Diane E. Sullivan was granted stock options and restricted stock units (RSUs) following Amarin's annual general meeting.

Summary

• Diane E. Sullivan, a director of Amarin Corp PLC, received stock options and restricted stock units (RSUs) on April 18, 2024.
• The stock options grant is for 179,795 ordinary shares with an exercise price of $0.87.
• These options vest over three years, with 33% vesting on the first anniversary and the remainder vesting in equal quarterly installments.
• Sullivan also received 50,287 RSUs, which vest in three equal installments annually starting April 18, 2025.
• Each RSU represents the right to receive one ordinary share or cash at the Issuer's discretion.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate governance practice of incentivizing directors with equity, which is generally viewed positively. There are no indications of negative performance or concerning issues.

Positives

• The grant of stock options and RSUs to a director aligns their interests with those of the shareholders.
• The vesting schedules encourage long-term commitment and performance.

Industry Context

Equity grants are a common practice in the pharmaceutical industry to incentivize and retain key personnel, aligning their interests with the long-term success of the company.

Comparison to Industry Standards

• Equity compensation packages for directors in the pharmaceutical industry typically include a mix of stock options and restricted stock units.
• The vesting schedules are generally structured to encourage long-term commitment, often over a threeto four-year period, which is consistent with the vesting schedule outlined in the document.
• Comparable companies such as Madrigal Pharmaceuticals, Viking Therapeutics, and Esperion Therapeutics also utilize similar equity-based compensation strategies for their directors.

Stakeholder Impact

• The equity grants align the director's interests with those of the shareholders, potentially leading to better corporate governance and strategic decision-making.
• Employees may view the equity grants as a positive sign of the company's commitment to its leadership.

Key Dates